Kalijev Klorid Jadran

Potassium Chloride, the active ingredient in Kalijev Klorid Jadran, is an electrolyte supplement presented as an oral dosage form for oral use. It helps correct hypokalemia and maintain normal cellular and cardiac function in patients requiring potassium replacement.

GNH USA supplies Kalijev Klorid Jadran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑regulated manufacturers and ensuring compliance with EU pharmacopeial standards.

Kalijev Klorid Jadran is used as an oral potassium chloride to address electrolyte disturbances related to low potassium.

Hypokalemia: Restores serum potassium to normal levels, reducing risk of cardiac arrhythmias. Potassium deficiency: Provides supplemental potassium to prevent muscle weakness and fatigue. Diuretic therapy: Replaces potassium lost during treatment with loop or thiazide diuretics.

Oral potassium chloride may be associated with a range of adverse reactions, most of which are mild and dose‑related.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Vomiting: occasional expulsion of stomach contents. - Abdominal discomfort: cramping or pain in the abdomen. - Diarrhea: loose stools. - Taste disturbance: metallic or salty taste. - Hyperkalemia (mild): slight elevation of serum potassium.

Serious or Rare Side Effects: - Severe hyperkalemia: marked increase in serum potassium leading to cardiac arrhythmia. - Cardiac arrest: life‑threatening rhythm disturbances. - Anaphylactic reaction: rare allergic response with hives, swelling, or breathing difficulty. - Severe skin rash: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before prescribing Kalijev Klorid Jadran, clinicians should consider several safety measures.

Monitor serum potassium: check levels before initiation and periodically during therapy. Adjust dose in renal impairment: reduce dosage or increase monitoring in patients with reduced kidney function. Use caution in cardiac disease: avoid rapid correction in patients with existing arrhythmias. Avoid in hyperkalemia: do not administer if serum potassium is already elevated. Review concomitant medications: assess for drugs that may increase potassium levels. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium chloride can interact with other medicines that affect potassium balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors: can cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): risk of severe hyperkalemia. - NSAIDs: may reduce renal potassium excretion, increasing serum levels.

Moderate Interactions (Monitor Closely): - Digoxin: elevated potassium may enhance digoxin toxicity. - Beta‑blockers: may mask symptoms of hyperkalemia. - Lithium: potassium levels influence lithium clearance.